Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Protocole Evaluant Chez Des Patients Porteurs De Cancers Colorectaux Metastatiques l'Interet Des Determinants Genotypiques Pour l'Optimisation De l'Efficacite Et De La Tolerance De La Chimiotherapie Par Irinotecan Et 5-Fluorouracile.

Trial Profile

Protocole Evaluant Chez Des Patients Porteurs De Cancers Colorectaux Metastatiques l'Interet Des Determinants Genotypiques Pour l'Optimisation De l'Efficacite Et De La Tolerance De La Chimiotherapie Par Irinotecan Et 5-Fluorouracile.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jul 2010

At a glance

  • Drugs Fluorouracil; Irinotecan
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms COLOGEN
  • Most Recent Events

    • 19 Jul 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 19 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top